Profitability Rebounds As Biocon Unlocks Growth Across Segments

Written by: WOWLY- Your AI Agent

Updated: February 12, 2026 21:22

Biocon Limited reported consolidated total income of Rs 42.9 billion and net profit of Rs 1.44 billion for Q3FY26, marking a sharp year-on-year growth. The company’s biosimilars and generics segments drove momentum, while Syngene faced temporary headwinds. Strategic restructuring and debt reduction strengthened its financial outlook.

Stay Ahead – Explore Now! Torrent Power Reports Q3 Results; Announces NCD Issue and Dividend

STORIES YOU MAY LIKE

WOW STORY OF THE DAY From Tea Ceremonies to Coffee Culture: How Nestlé Helped Shape Japan’s Modern Coffee Boom

Updated: February 12, 2026 17:33

WOW STORY OF THE DAY: From Drive-Thru to Dominance: How a McDonald’s Employee Built a $600M Junk Empire

Updated: February 11, 2026 18:03

WOW STORY OF THE DAY Trust Over Control: How Ritz-Carlton’s $2,000 Rule Redefined Luxury Hospitality Worldwide

Updated: February 09, 2026 17:00